Product Orders
(866) 246-6990 USA Product orders by FAX: (866) 804-9881 USA Email Customer Service Contact Us Form
Power of thrombin with the antimicrobal properties of silver
Thrombin is a powerful clotting agent and platelet aggregator which reduces time-to-hemostasis.1,2 Silver Topical Hemostat chloride (available in D-Stat® Dry Silver Topical Hemostat products only) is an active antimicrobial which prevents microorganisms from colonizing on the pad.
Clinical data to support a true hemostat
Results from a 376-patient, five-center, prospective randomized U.S. clinical study evaluating D-Stat® Dry Topical Hemostat as an adjunct to hemostasis in diagnostic femoral catheterizations using 4-6 Fr. introducer sheaths compared to standard manual compression (control).1,2
Time-To-Hemostasis (TTH) Results |
|
|
Median TTH (mins) |
|
|
Mean TTH (mins)** |
|
|
± Standard Deviation |
|
|
Range (min/max) |
|
|
**p-value of 0.001 calculated using Wilcoxon’s Signed-Rank Test |
Medication Status |
|
|
|
Not anti-coagulated |
|
|
|
Anti-coagulated5 |
|
|
|
*Applicable to diagnostic procedures only. |
99.99% microbial kill rate6,7
D-Stat Dry® Silver Topical Hemostat demonstrated for seven microorganisms commonly
encountered in the clinical setting, including MRSA, MRSE, and VRE
Also available are the Thrombix® and Thrombix® Silver Topical Hemostats. Both patches are low-profile with the power of thrombin to facilitate hemostasis following endovascular procedures. The Thrombix® Silver Topical Hemostat contains silver chloride to prevent microorganisms commonly encountered in the clinical setting from colonizing on the pad.
WARNING: SEVERE
BLEEDING AND THROMBOSIS COMPLICATIONS
- THROMBIN-JMI® can cause fatal severe bleeding or thrombosis. Thrombosis may
result from the development of antibodies against bovine thrombin. Bleeding may result from the
development of antibodies against factor V. These may cross-react with human factor V and lead to
its deficiency.
- Do not re-expose patients to THROMBIN-JMI® if there are known or suspected
antibodies to bovine thrombin and/or factor V.
- Monitor patients for abnormal coagulation laboratory values, bleeding, or thrombosis.